Previous Close | 319.20 |
Open | 321.00 |
Bid | 318.00 x 50000 |
Ask | 326.50 x 50000 |
Day's Range | 321.00 - 323.20 |
52 Week Range | 306.50 - 499.70 |
Volume | |
Avg. Volume | 3 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LOUISVILLE, Ky., March 20, 2024--Humana Inc. (NYSE: HUM) and DUOS, a technology-enabled service provider announces a new collaborative program to enhance the healthcare experience and improve health outcomes for Louisiana Veteran members with chronic conditions.
LOUISVILLE, Ky., March 13, 2024--Humana Inc. (the "company") (NYSE: HUM) announced today the completion of its public offering of $2.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $1.25 billion of the company’s 5.375 percent senior notes, due 2031, at 99.940 percent of the principal amount, and $1.00 billion of the company’s 5.750 percent senior notes, due 2054, at 99.949 percent of the principal amount (collectively, the "Senior Notes Offerings").
OLDWICK, N.J., March 13, 2024--AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "bbb" (Good) to Humana Inc.’s (Humana) (headquartered in Louisville, KY) [NYSE: HUM] recently announced $1.25 billion 5.375% senior unsecured notes, due 2031, and $1 billion 5.75% senior unsecured notes, due 2054. In addition, AM Best has assigned indicative Long-Term IRs of "bbb" (Good) to senior unsecured issues, "bbb-" (Good) to subordinated issues and "bb+" (Fair) to preferred stock and of t